幼年与成人起病皮肌炎的疾病严重程度与活动度比较:多中心队列研究
该多中心队列纳入201例符合2017 ACR/EULAR标准且检测肌炎特异性抗体的皮肌炎患者,比较幼年(jDM,78例)与成人(aDM,123例)起病者的诊断时严重程度及随访疾病活动度。结果显示44%病例诊断时存在严重疾病,成人以症状性ILD更常见、儿童以GI血管炎更常见,但末次随访临床 inactive 疾病或缓解无显著差异。
要点
- jDM中抗NXP2抗体和关节受累与诊断时严重疾病相关,aDM中抗Mi2抗体与较低严重疾病风险相关。
- 成人症状性ILD更常见,儿童GI血管炎更常见,严重肌肉病变无差异。
- 末次随访临床 inactive 疾病或缓解在jDM与aDM间无显著差异。
核心结论
- 皮肌炎的严重程度谱随起病年龄不同而异,自身抗体是jDM和aDM诊断时严重程度的关键指标。
研究设计与样本
- 多中心队列研究,纳入201例符合2017 ACR/EULAR标准且检测肌炎特异性抗体的皮肌炎患者,其中aDM(≥18岁)123例、jDM(<18岁)78例。
主要发现
- 诊断时严重疾病见于44%的病例,症状性ILD在成人更常见,GI血管炎在儿童更常见,严重肌肉病变无差异。
- jDM中抗NXP2抗体(OR=6.29 [2.00, 23.07],P=0.003)和关节受累(OR=3.44 [1.33, 11.47],P=0.03)与诊断时严重疾病相关。
- aDM中抗Mi2抗体与较低严重疾病可能性相关(OR=0.12 [0.02, 0.42],P=0.003)。
- 末次随访时临床 inactive 疾病或缓解在jDM与aDM间无显著差异,严重感染发生于25%的患者。
关键数值与推荐
- 诊断时总体严重程度定义为至少满足以下一项:严重肌肉损害、症状性ILD、GI血管炎、心肌炎、严重皮肤溃疡或入住ICU。
- 临床 inactive 疾病和缓解依据PRINTO组标准和IMACS指南定义。
临床怎么用
- 对jDM患者应关注抗NXP2抗体和关节受累以识别诊断时严重疾病高风险者。
- 对aDM患者抗Mi2抗体可能提示较低严重疾病风险,但仍需结合临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the severity at diagnosis and disease activity during follow-up between juvenile (jDM) and adult-onset (aDM) dermatomyositis. METHODS: Patients with DM fulfilling the 2017 ACR/EULAR criteria and tested for myositis-specific antibodies were included. Overall severity at diagnosis was defined by at least one of the following: severe muscle impairment, symptomatic interstitial lung disease (ILD), gastrointestinal (GI) vasculitis, myocarditis, severe skin ulceration or admission to an intensive care unit. Clinically inactive disease and remission were defined according to PRINTO group criteria and IMACS guidelines. RESULTS: Two hundred and one patients were included: 123 with aDM (≥18 years) and 78 with jDM (<18 years). Female predominance was less pronounced and GI involvement was more frequent in jDM. Anti-nuclear matrix protein 2 (NXP2) antibodies (Abs) were more frequent in jDM. Severe disease at diagnosis was present in 44% of cases, with symptomatic ILD more common in adults and GI vasculitis more common in children. No difference was observed in severe muscle disease. In jDM, anti-NXP2 Abs (odds ratio [OR] = 6.29 [2.00, 23.07], P = 0.003) and joint involvement (OR = 3.44 [1.33, 11.47], P = 0.03) were associated with severe disease at diagnosis, while in aDM, anti-Mi2 Abs were associated with a lower likelihood of severe disease (OR = 0.12 [0.02, 0.42], P = 0.003). No significant difference was observed in clinically inactive disease or remission at the last follow-up. Severe infections occurred in 25% of patients. CONCLUSION: Severity profiles differ by age of DM onset. Autoantibodies are key indicators of severity at diagnosis in both juvenile DM and adult DM.
引用
- Sinnaeve A, Bader-Meunier B, Mirguet A, et al. Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicentre cohort study. Rheumatology (Oxford). 2026. PMID: 41578950. doi:10.1093/rheumatology/keag032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。